![](/img/cover-not-exists.png)
Three-year follow-up of galantamine therapy for Alzheimer's disease: Efficacy and tolerability in open-label extension studies
G. Wilcock, L. TruyenVolume:
12
Year:
2002
Language:
english
DOI:
10.1016/s0924-977x(02)80622-8
File:
PDF, 254 KB
english, 2002